Categories
Weight Loss Products

Science or Snake Oil: is Garcinia cambogia the magic weight-loss pill it’s hyped up to be?

The burgeoning field of complementary medicines, including weight-loss products, is now a billion-dollar industry. Every year, more people are spending disposable income on complementary and alternative medicines that may prove to have no benefit for our health.

Garcinia Cambogia is one such example. Marketed as a weight-loss pill, it has had an exponential rise in sales since it was featured on the Doctor Oz show.

Garcinia cambogia is the former scientific name of a native Southeast Asian plant, belonging to the family Clusiaceae, that bears a pumpkin-shaped fruit. The skin of the fruit contains the active ingredient, hydroxycitric acid (HCA). HCA inhibits an enzyme that produces fatty acid, thus suppressing fatty acid and the processing of cholesterol.

But does this mode of action translate to the weight-loss claims associated with it? Or is it just clever marketing convincing us this product helps us lose weight?

An Australian advertisement for the weight-loss supplement Garcinia Cambogia.
Screenshot, http://www.garciniacambogiasave.com/, CC BY

Double-blinded, randomised controlled trials are the gold standard of clinical study and whenever possible should be conducted to test the effectiveness of a treatment compared to a placebo. Weight-loss products should be assessed for a minimum of six months, with a further six-month follow-up period (12 months total).

There has never been a long-term study investigating the efficacy of Garcinia Cambogia. Most of the studies have been conducted in animals.

In fact, the majority of well-designed trials investigating the effect of this product on weight loss have found no effect that is of clinical relevance. In a 12-week double-blind, placebo-controlled trial conducted in humans, people receiving 3000mg of Garcinia Cambogia extract (1500mg of the active component HCA) per day lost the same amount of weight as the control group.

Another 12-week study with a four-week follow-up (16 weeks total) also found no greater weight-loss effect than for a placebo control group. For those studies where a statistically significant effect was reported, the weight loss was around one kilogram more than for those receiving a placebo pill.

Positive and greater weight losses were found in some studies, but this effect is suppressed when looking at all of the studies combined.

The Garcinia Cambogia plant.
Livia Lacolare/Flickr, CC BY

With respect to other health benefits from taking this supplement, the evidence to suggest it can improve blood cholesterol levels is lacking.

Most importantly, the product safety profile of Garcinia Cambogia has been adequately tested and there appear to be no issues.

Some complementary medicines have been found to contribute to improved health outcomes, through increased efficacy and cost-effectiveness. However, if there is to be a role for such complementary and alternative weight-loss products and medicines, we must build upon the evidence to investigate whether these increasingly popular products are a viable treatment option.

A recent Obesity Australia and Price Waterhouse Coopers report found obesity cost Australia A$8.6 billion in 2011-2012, with the indirect costs far higher. We must establish whether complementary medicines have a role to play in preventing and treating obesity. If we take no action to reduce obesity rates, an additional 2.4 million people will become obese at a cost of $87.7 billion over 10 years.


Please visit this website if you’re interested in taking part in our clinical weight-loss trials on Garcinia Cambogia and other weight-loss supplements.

Categories
Weight Loss Products

The FTC just prosecuted a fake paid Amazon review for the first time — here’s what that means for users

<!– –>


VISIT CNBC.COM


Success

12:35 PM ET Fri, 1 March 2019

Amazon boxes are seen stacked for delivery in New York City.

Thanks to fake reviews on sites like Amazon and Yelp, it can be hard to trust what you read. Now however, the US government has begun cracking down on fake user reviews posted on Amazon.

On Wednesday, the Federal Trade Commission announced its first-ever charges against a company that paid to have fake reviews posted online. The company in question, New York-based Cure Encapsulations, paid the third-party website amazonverifiedreviews.com to write and post positive reviews that appeared to come from consumers for a weight-loss supplement product on Amazon.com, according to the FTC.

“Please make my product … stay a five star,” Cure Encapsulations owner Naftula Jacobowitz told amazonverifiedreviews.com, according to the FTC. Jacobowitz’s company paid for reviews falsely describing its product, the supplement garcinia cambogia, as a “powerful appetite suppressant” that “literally blocks fat from forming,” the FTC says.

Will it make reviews more trustworthy?

The FTC “does not comment about what future actions it may or may not take,” a spokesperson told CNBC Make It. But the fact that the FTC brought the case has already sparked speculation that the case sets the precedent that the federal government is now willing to bring charges against companies that pay for fake reviews making misleading claims.



How this young Indiana couple stole $1.2 million from Amazon



Fake online reviews are a common problem on e-commerce sites like Amazon and have also shown up on online review platforms like Yelp. Still, roughly 86 percent of consumers still regularly read online reviews, and a majority of people say that positive reviews make them more likely to use a local business, according to a BrightLocal survey.

Cases like the FTC’s settlement with Cure Encapsulations should make it easier for consumers to trust online reviews on sites like Amazon, according to Paul Alan Levy, an attorney who works for the consumer-advocacy group Public Citizen.

“I think it gives consumers more reason to place trust in what they see on these review sites, certainly,” Levy tells CNBC Make It.

“The administrative agencies, like the FTC and state attorneys general, are in an excellent position to do investigations and figure out when there are false positive [reviews] out there, and it’s good that the FTC is doing that, because it creates a sort of pressure on avoiding false positive reviews,” he tells CNBC Make It.

Squashing fake reviews

Levy notes that, in the past, e-commerce companies and review sites have sometimes taken matters into their own hands when looking to squash fake reviews. Amazon itself has filed numerous lawsuits in recent years against sellers who post false reviews, as well as third-party companies that sell the service of posting fake reviews. Amazon estimated last year that “less than 1 percent of reviews are inauthentic” on the site.

“We welcome the FTC’s work in this area,” an Amazon spokesperson told The Verge. “Amazon invests significant resources to protect the integrity of reviews,” but “even one inauthentic review is one too many.” (The company also announced a new program, called Project Zero, targeting counterfeit goods on the site on Thursday.)

Yelp also has its own Consumer Alerts program that tries to catch businesses that post fake reviews.

Of course, Levy also points out that consumers should still take online reviews with a grain of salt.

“The wisdom of the crowd on review sites has value for consumers,” he says, “[but] you should never take a single review as gospel, whether it be a five-star review or a one-star review.” Instead, he says, look for a pattern of reviews.

The FTC case

The FTC filed its complaint against Cure Encapsulations last week, after finding that the company had paid for the fabricated reviews, which purported to be written by actual customers and which made “false and unsubstantiated claims” about its products. While the extract garcinia cambogia is often claimed to be effective for weight-loss, the National Institutes of Health has noted that there is “no convincing evidence” that it can help you lose weight.

Cure Encapsulations has already reached a settlement with the FTC in which the company has agreed to never again make “weight-loss, appetite-suppression, fat-blocking, or disease-treatment claims” for any product without substantiating those claims with “competent and reliable scientific evidence,” the FTC says. The settlement also prohibits the company from misrepresenting endorsements, including reviews that falsely claim to come from an actual customer.

“People rely on reviews when they’re shopping online,” Andrew Smith, Director of the FTC’s Bureau of Consumer Protection, said in a statement. “When a company buys fake reviews to inflate its Amazon ratings, it hurts both shoppers and companies that play by the rules.”

Correction: This article was revised to correct Cure Encapsulation’s location. The company is headquartered in New York.

Don’t Miss:

How to start a successful Amazon business, from a seller who’s making millions

Like this story? Subscribe to CNBC Make It on YouTube!



This high school dropout brought in $18 million last year selling on Amazon



a:after {content: “203A”;font-size:1.25em;margin-left:1px;}
.wildcard .prime_promo_module h3.content-title{font-size:20px;line-height:26px;}
@media screen and (max-width: 600px){
.video-wrapper {display: inline-block;width: 47%;}
}
@media screen and (max-width: 530px){
.wildcard .prime_promo_module {margin: 20px 10px!important;}
.wildcard .prime_promo_module .sourceName.top a {font-size: 14px; color:white;}
.video-wrapper { display: inline-block;width: 100%;}
.poster-wrapper {max-width: 100%;}
.video-info {margin-left: 0px;width: 100%;max-width: 530px;}
.prime_promo_module i.fa.fa-video {font-size: 3.5em;margin: 55px 105px;}
.prime_promo_module .top{margin:0px;}
body[id*=makeit] .show-name.top a {font-size: 14px;}
h3.content-title {font-size: 22px;line-height: 26px;}
.immersive article .tuneIn p {font-size: 15px;}
}
]]>


Playing

Share this video…

Watch Next…

i_am_old_ie = true;

Data is a real-time snapshot *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

Data also provided by

© 2019 CNBC LLC. All Rights Reserved. A Division of NBCUniversal

Categories
Weight Loss Products

Can NUTRAFUELS INC (OTCMKTS:NTFU)’s Tomorrow Be Different? The Stock Had Decline in Shorts | Thorold News

The stock of NUTRAFUELS INC (OTCMKTS:NTFU) registered a decrease of 32% in short interest. NTFU’s total short interest was 8,500 shares in March as published by FINRA. Its down 32% from 12,500 shares, reported previously. With 78,600 shares average volume, it will take short sellers 0 days to cover their NTFU’s short positions.

The stock increased 0.63% or $0.0011 during the last trading session, reaching $0.175. About 6,925 shares traded. NutraFuels, Inc. (OTCMKTS:NTFU) has 0.00% since March 5, 2018 and is . It has underperformed by 4.37% the SP500.

NutraFuels, Inc. manufactures and distributes oral spray nutritional and dietary products to retail and wholesale outlets. The company has market cap of $18.60 million. The companyÂ’s products include sleep spray to support a healthy sleep cycle and improve the quality of restful sleep; energize spray to enhance energy, and restore vigor and vitality; and garcinia cambogia spray, an appetite and weight management spray. It currently has negative earnings. It also offers NRG-X extreme energy spray to enhance energy and stamina; headache and pain spray to relieve headaches and pain; and hair, skin, and nails spray to nourish and encourage hair, skin, and nail growth.

More news for NutraFuels, Inc. (OTCMKTS:NTFU) were recently published by: Globenewswire.com, which released: “Freedom Leaf Inc. Announces National Distribution Agreement Other OTC:FRLF – GlobeNewswire” on February 28, 2018. Marketwired.com‘s article titled: “NutraFuels (NTFU) Files its Application to Up List to the OTCQB OTC Market – Marketwired” and published on January 29, 2018 is yet another important article.

Receive News Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.